85 related articles for article (PubMed ID: 93762)
1. [Clinical and biochemical contributions on the action of maprotiline and clomipramine in depressive states (preliminary observation)].
Ravizza L
Psychiatr Clin (Basel); 1979; 13(3):164-72. PubMed ID: 93762
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and biochemical contributions on the effect of maprotiline and clomipramine in depressive states (preliminary observation)].
Ravizza L
Psychiatr Clin (Basel); 1979; 12(3):164-72. PubMed ID: 94169
[TBL] [Abstract][Full Text] [Related]
3. Amine metabolism, thyroid function and response to clomipramine and maprotiline medication in depression.
Ridges AP; Bishop FM; Lawton K; Goldberg IJ
Postgrad Med J; 1980; 56 Suppl 1():37-41. PubMed ID: 6156444
[TBL] [Abstract][Full Text] [Related]
4. Uptake of 5-hydroxytryptamine and dopamine into platelets from depressed patients and normal subjects--influence of clomipramine, desmethylclomipramine and maprotiline.
Ehsanullah RS
Postgrad Med J; 1980; 56 Suppl 1():31-5. PubMed ID: 7393826
[TBL] [Abstract][Full Text] [Related]
5. Urinary amine metabolites in depression: a combined biochemical and general practice study: II. Biochemical aspects.
Ridges AP; Bishop FM; Goldberg IJ
J Int Med Res; 1980; 8 Suppl 3():37-44. PubMed ID: 6162689
[TBL] [Abstract][Full Text] [Related]
6. The Harold E. Himwich Memorial Lecture. Significance of biochemical parameters in the diagnosis, treatment, and prevention of depressive disorders.
Praag HM
Biol Psychiatry; 1977 Feb; 12(1):101-31. PubMed ID: 300032
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and experimental experiences with maprotiline, clomipramine, sydnocarb and mefexamide in mentally-ill patients and in healthy persons].
Zapletálek M; Hübsch T; Zbytovský J; Polácková J; Kindernayovä H
Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(2):323-34. PubMed ID: 333568
[TBL] [Abstract][Full Text] [Related]
8. Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
Ridges AP
Postgrad Med J; 1977; 53 Suppl 4():24-9. PubMed ID: 341107
[No Abstract] [Full Text] [Related]
9. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
Zapletálek M; Zbytovský J; Kudrnová K
Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
[TBL] [Abstract][Full Text] [Related]
10. Antidepressive treatment and mood swing patterns in endogenous depression.
Strian F; Albert W; Klicpera C
Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):432-7. PubMed ID: 538088
[TBL] [Abstract][Full Text] [Related]
11. [Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)].
Schlienger JL; Kapfer MT; Singer L; Stephan F
Acta Psychiatr Belg; 1980; 80(5):584-99. PubMed ID: 6786002
[TBL] [Abstract][Full Text] [Related]
12. Urinary amine metabolites in depression: a combined biochemical and general practice study: I. Clinical aspects.
Parrack S; Ridges AP
J Int Med Res; 1980; 8 Suppl 3():27-36. PubMed ID: 7202816
[TBL] [Abstract][Full Text] [Related]
13. [Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
Soucek K
Act Nerv Super (Praha); 1982 May; 24(2):88-9. PubMed ID: 7102229
[No Abstract] [Full Text] [Related]
14. [Treatment of depression with intravenous infusions of clomipramine and maprotiline].
Bogdanowicz E; Kalinowski A; Swiecicki L
Psychiatr Pol; 1991; 25(3-4):19-24. PubMed ID: 1821972
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of maprotiline (ludiomil) and clomipramine (anafranil) on serotonin uptake and tryptophan-binding in plasma.
Greengrass PM; Waldmeier PC; Imhof PR; Maitre L
Biol Psychiatry; 1976 Feb; 11(1):91-100. PubMed ID: 1260079
[TBL] [Abstract][Full Text] [Related]
16. [Management of treatment-resistant depression (author's transl)].
Kielholz P; Terzani S; Gastpar M
Dtsch Med Wochenschr; 1978 Feb; 103(6):241-3. PubMed ID: 627181
[TBL] [Abstract][Full Text] [Related]
17. On the tryptophan-serotonin metabolism in manic-depressive disorders. Changes in plasma 5-HT and 5-HIAA levels and urinary 5-HIAA excretion following oral loading of L-5HTP in patients with depression.
Amamoto T; Sarai K
Hiroshima J Med Sci; 1976 Sep; 25(2-3):135-40. PubMed ID: 1088369
[No Abstract] [Full Text] [Related]
18. Therapeutic effect of maprotiline and chlorimipramine: controlled study.
Montejo-Iglesias ML; Ramos-Brieva JA
Neuropsychobiology; 1988; 19(1):20-4. PubMed ID: 3054622
[TBL] [Abstract][Full Text] [Related]
19. [The clomipramine-lithium combination: controlled trial].
Nick J; Luaute JP; Des Lauriers A; Moinet A; Monfort J
Encephale; 1976; 2(1):5-16. PubMed ID: 770150
[TBL] [Abstract][Full Text] [Related]
20. Intravenous maprotiline in severe and resistant primary depression: a double-blind comparison with clomipramine.
Drago F; Motta A; Grossi E
J Int Med Res; 1983; 11(2):78-84. PubMed ID: 6343154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
